Onpattro 2 mg/mL
patisiran · INJECTION, LIPID COMPLEX · Alnylam Pharmaceuticals, Inc.
No Recall History
Plain English
Onpattro is a injection, lipid complex containing patisiran at 2 mg/mL, taken intravenous. Manufactured by Alnylam Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Onpattro
- Generic Name
- patisiran
- NDC Code (Product)
71336-1000- Manufacturer
- Alnylam Pharmaceuticals, Inc.
- Strength
- 2 mg/mL
- Dosage Form
- INJECTION, LIPID COMPLEX
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA210922
- Marketing Start
- 08/13/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Onpattro used for?
Onpattro contains patisiran. It is a injection, lipid complex taken intravenous. Consult your doctor for specific uses.
Is Onpattro a controlled substance?
Onpattro is not classified as a controlled substance by the DEA.
What is the generic name for Onpattro?
The generic name for Onpattro is patisiran. There are no other listed brand versions of patisiran.
What is the NDC code for Onpattro 2 mg/mL?
The NDC (National Drug Code) for Onpattro 2 mg/mL is 71336-1000, listed by Alnylam Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)